Cytotoxic Activity of Flavonols from Macaranga gigantea (Rchb.f. & Zoll.) Müll.Arg.

Authors

  • Rino Wanandri Salam Rewa Universitas Airlangga
  • Ratih Dewi Saputri Universitas Airlangga
  • Tjitjik Srie Tjahjandarie Universitas Airlangga
  • Mulyadi Tanjung Universitas Airlangga

DOI:

https://doi.org/10.30595/pharmacy.v17i2.7649

Keywords:

cytotoxic, flavonol, glyasperin A, meliternatin, Macaranga gigantea

Abstract

Two flavonols, glyasperin A (1), and meliternatin (2) has been isolated from the leaves of Macaranga gigantea (Rchb.f. & Zoll.) Müll.Arg. Extraction and isolation of flavonols were used methanol with the maceration method. The process of fractionation and purification used column chromatography and radial chromatography. The structure of both flavonols was determined by spectroscopic methods, including UV-Vis, IR, HRESIMS, 1D NMR (1H, and 13C-NMR) and 2D NMR (HMBC and HMQC). The cytotoxic activity of glyasperin A (1), and meliternatin (2) toward P-388 leukemia murine cells by MTT method, showing IC50 values 3.44 and 30.04 µg/mL, respectively.

Author Biography

Mulyadi Tanjung, Universitas Airlangga

Departemen Kimia

References

Agustina, W., Juliawaty, L.D., Hakim, E.H., Syah, Y. M. 2012. Flavonoids from Macaranga lowii. J. Math. Fund. Sci., 44, 13–18 (2012).

Aldin, M.F., Saputri, R.D., Tjahjandarie, T.S., Tanjung, M. 2019. Aktivitas antikanker senyawa stilbenoid dari daun Macaranga aleuritoides, Pharm. Med. J., 2, 1-7.

Beutler, J.A., Shoemaker, R.H., Johnson, T., Boyd, M.R. 1998. Cytotoxic geranyl stibenes from Macaranga schweinfurthii, J. Nat. Prod., 61, 1509-1512.

Blattner, F.R., Weising, K., Banfer, G., Mascwitz, U., Fiala, B. 2001. Molecular analysis of phylogenetic relationships among myrmecophytic Macaranga species (Euphorbiaceae). Mol. Phyl. Evol. 19, 331-344.

Heyne, K. 1987. Tumbuhan Berguna Indonesia. Badan Litbang Kehutanan, Jakarta, 5876.

Magadula, J.J. 2014. Phytochemistry and pharmacology of the genus Macaranga: a review, J. Med. Plant Res. 8(21), 489-503.

Pialee, P., Sangpetsiripan, S., Mahidol, C., Ruchirawat, S., Prachyawarakorn, V. 2015. Cytotoxic and cancer chemopreventive properties of prenylated stilbenoids from Macaranga siamensis, Tetrahedron, 71, 5562-5571.

Peresse, T., Jezequel, G., Allard, P-M., Pham, V-C., Huong, D.T.M., Blanchard, F., Bignon, J., Levaique, H., Wolfender, J-L., Litaudon, M., Roussi, F. 2017. Cytotoxic prenylated stilbenoids isolated from Macaranga tanarius, J. Nat. Prod., 80(10), 2684-2691.

Tanjung, M., Juliawaty, L.D., Hakim, E.H., Syah, Y.M. 2018. Flavonoid and stibene derivatives from Macaranga trichocarpa. Fitoterapia. 126, 74–77.

Tanjung, M., Rachmadiarti, F, Prameswari, A., Agyani, V.U.W., Saputri, R.D., Tjahjandarie, T.S., Syah Y.M. 2018. Airlanggins A-B, two new isoprenylated benzofuran-3-ones from the stem bark of Calophyllum soulattri, Nat. Prod. Res. 32, 1493-1498.

Tanjung, M., Tjahjandarie, T.S. 2014. Dihydroflavonols from the leaves of Macaranga recurvata. J. Chem. Pharm. Res. 6, 90-95.

Tanjung, M., Hakim, E.H., Mujahidin, D., Hanafi, M., Syah, Y.M. 2009. Macagigantin, a farnesylated flavonol from Macaranga gigantea, J. Asian Nat. Prod. Res. 11, 929-932.

Tjahjandarie, T.S., Tanjung, M., Saputri, R.D., Rahayu, D.O., Gunawan, A.N.I., Aldin, M.F. 2020. Two new 2-arylbenzofurans from Sesbania grandiflora L. and their cytotoxicity toward cancer cell. Nat. Prod. Res., 1-6.

Tjahjandarie, T.S., Tanjung, M., Saputri, R.D., Nadar, P.B., Aldin, M.F., Marliana, E., Permadi, A. 2019. Flavestin K, an isoprenylated stilbene from the leaves of Macaranga recurvata Gage, Nat. Prod. Sci. 25(3), 244-247.

Saputri R.D., Tjahjandarie T.S., Tanjung M. 2018. Meliglabrin, a new flavonol derivative from the leaves of Melicope glabra (Blume) T.G. Hartley. Nat Prod Sci. 24, 155-158.

Downloads

Published

2020-12-31

How to Cite

Rewa, R. W. S., Saputri, R. D., Tjahjandarie, T. S., & Tanjung, M. (2020). Cytotoxic Activity of Flavonols from Macaranga gigantea (Rchb.f. & Zoll.) Müll.Arg. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 17(2), 360–367. https://doi.org/10.30595/pharmacy.v17i2.7649